CEO interview with Victoire Viannay

“Fluicell is now taking important steps forward to become a leading force for better health”

In this new interview, published by Stockpicker, CEO Victoire Viannay talks about Fluicell’s plans to create opportunities for better health through precission research tools, tissue-based disease models for drug development and regenerative medicine – all made possible by our high-precision 3D bioprinting platform Biopixlar.

Check it out: (in Swedish)